Home » Authors » Don Long

Articles by Don Long

Bone scan detecting metabolic changes is better knee OA test

April 1, 2004

Cepheid Raising $62M Through Public Offering Of 5.5M Shares

Feb. 13, 2004

Cepheid Raising $62M Through Public Offering Of 5.5M Shares

Feb. 13, 2004

CryoLife Privately Raises $20M, Calls Near Term 'Very Promising'

Jan. 27, 2004

CryoLife Privately Raises $20M, Calls Near Term 'Very Promising'

Jan. 27, 2004

Earlier discovery of lung cancer key focus of new tech roll-outs

Jan. 1, 2004

Optimizer II seeks a niche in weaponry against heart failure

Dec. 1, 2003

Vitex Halts Phase III Chronic Trial Of Inactine, Seeks New Financing

Nov. 19, 2003

Vitex Halts Phase III Chronic Trial Of Inactine, Seeks New Financing

Nov. 19, 2003

Still Focused On Intercept, Cerus Cuts Work Force By 25 Percent

Oct. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...